← Evidence map

ArticleEMBO molecular medicine2026

CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastoma.

Silje Lier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41882177